Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Heico
HEI
5
Jefferies Financial
JEF
CA Stock MarketDetailed Quotes
DTR DiagnosTear Technologies Inc
- 0.240
- +0.030+14.29%
15min DelayTrading May 8 09:30 ET
14.11MMarket Cap-0.52P/E (TTM)
0.240High0.240Low500Volume0.240Open0.210Pre Close120.00Turnover0.75052wk High0.00%Turnover Ratio58.79MShares0.20052wk Low-0.46EPS TTM10.60MFloat Cap0.750Historical HighLossP/E (Static)44.18MShs Float0.200Historical Low-0.46EPS LYR0.00%Amplitude--Dividend TTM4.21P/B1Lot Size--Div YieldTTM
About DiagnosTear Technologies Inc Company
DiagnosTear Technologies Inc is an ophthalmic company developing and commercializing disruptive diagnostic solutions for management of eye diseases. The company is developing different tests based on the TeaRx platform for additional ophthalmic indications. Its pipeline includes TeaRx Red Eye; The first test of its kind for differential assessment of adenoviral conjunctivitis, Herpetic Keratitis and Allergic conjunctivitis.
Company Profile
SymbolDTR
Company NameDiagnosTear Technologies Inc
Founded2023
MarketCNQ
Fiscal Year Ends12-31
Address10 Menachem Plaut Street
CityRehovot
CountryIsrael
Zip Code7670621
Phone+972 523408550
Websitehttp://www.diagnos-tear.com
Company Executives
No Data
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting